Mithril Capital Management — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
BiotechWaltham, US
Tillman U. Gerngross(Executive Officer, Director)Lynn Connolly(Executive Officer)Eric Kimble(Executive Officer)Halley Gilbert(Executive Officer)Rebecca Dabora(Executive Officer)Ellie Hershberger(Executive Officer)
Board seatAjay Royan· per SEC Form D · $335.5M raise · filed Apr 2021
Co-investorsPolaris PartnersVeltro Argento
Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Tillman Gerngross(Executive Officer, Director)
BoardTerrance McGuire(Director)
Board seatAjay Royan· per SEC Form D · $45M raise · filed Sep 2021
Co-investorsGV (Google Ventures)Polaris Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.